GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-115494 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET

7.1 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Sanofi S.A.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Shire plc

16.3 Pfizer, Inc.

16.4 Alexion Pharmaceuticals, Inc.

16.5 BioMarin Pharmaceutical Inc.

16.6 Ultragenyx Pharmaceutical Inc

16.7 Jassen Pharmaceuticals

16.8 Suneva Medical, Inc

16.9 Teoxane

16.10 Cynosure

16.11 Syneron

16.12 AQTIS Medical

16.13 Bioha Laboratories

16.14 Cytophil, Inc.

16.15 Dr. Korman Laboratories

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Therapeutic condition
Gaucher Disease
 o Type 1 (non-neuropathic)
 o Type 2 (acute infantile neuronopathic)
 o Type 3 Gaucher disease (chronic neuronopathic)
 o Perinatal lethal Gaucher disease
 o Cardiovascular Gaucher disease
Pompe Disease
 o Classic infantile-onset
 o Non-classic infantile-onset
 o Late-onset

By Route of Administration  
Oral
Parenteral

By Distribution Channel
Hospital Pharmacies
Specialty Treatment Pharmacies
Retail Pharmacies
Online Pharmacies

Companies

Sanofi S.A.
Shire plc
Pfizer, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc
Jassen Pharmaceuticals
Suneva Medical, Inc
Teoxane
Cynosure
Syneron
AQTIS Medical
Bioha Laboratories
Cytophil, Inc.
Dr. Korman Laboratories

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.